Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
2(22%)
Results Posted
17%(1 trials)

Phase Distribution

Ph phase_2
4
44%
Ph phase_3
2
22%
Ph not_applicable
1
11%

Phase Distribution

0

Early Stage

4

Mid Stage

2

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
4(57.1%)
Phase 3Large-scale testing
2(28.6%)
N/ANon-phased studies
1(14.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(2)
Completed(6)
Other(1)

Detailed Status

Completed6
Recruiting2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 24 (57.1%)
Phase 32 (28.6%)
N/A1 (14.3%)

Trials by Status

completed667%
recruiting222%
unknown111%

Recent Activity

2 active trials
Showing 5 of 9
recruitingphase_3

Human Recombinant Interferon Gamma in the Treatment of Ventilator-acquired Pneumonia in ICU Patients

NCT05843786
recruiting

The 1st Tumor CytokinoTherapy Database (TCTD-1)

NCT06222801
unknownnot_applicable

Impact of A. Lumbricoides on Pulmonary Aspergillosis Development

NCT05783544
completed

Study of the Use of the Drug Ingaron in Patients With COVID-19

NCT05386459
completedphase_3

Phase III Randomized Study of Interferon Gamma in Children With Severe, Congenital Osteopetrosis

NCT00004402
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT05843786Phase 3

Human Recombinant Interferon Gamma in the Treatment of Ventilator-acquired Pneumonia in ICU Patients

Recruiting
NCT06222801

The 1st Tumor CytokinoTherapy Database (TCTD-1)

Recruiting
NCT05783544Not Applicable

Impact of A. Lumbricoides on Pulmonary Aspergillosis Development

Unknown
NCT05386459

Study of the Use of the Drug Ingaron in Patients With COVID-19

Completed
NCT00004402Phase 3

Phase III Randomized Study of Interferon Gamma in Children With Severe, Congenital Osteopetrosis

Completed
NCT00501644Phase 2

Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer

Completed
NCT00001905Phase 2

Interferon Gamma to Treat Leukocyte Adhesion Deficiency Type I

Completed
NCT00001407Phase 2

Interferon Gamma for Drug Resistant Tuberculosis

Completed
NCT00001318Phase 2

Treatment of Non-Tuberculous Mycobacterial Infections With Interferon Gamma

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9